FLYER | Access Consortium

A collaborative initiative between five Health Authorities

A collaborative initiative between five Health Authorities

The Access Consortium is a collaborative initiative between five Health Authorities: Australia’s Therapeutic Goods Administration (TGA), Health Canada (HC), Singapore’s Health Sciences Authority (HSA), the Swiss Agency for Therapeutic Products (Swissmedic) and the Medicines and Healthcare products Regulatory Agency (MHRA) of the UK.

It intends to build synergies and maximize international cooperation to ensure patients’ timely access to safe therapeutic products in the member countries.

If you require any further information, contact us at: [email protected] 

 

Download here:

Share

LinkedIn
WhatsApp
Email
Access consortium
November 21, 2022
| By Asphalion

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting